De Novo Design of Hexamer‐Linker Dual‐Action Nano‐PROTAC for Tumor‐Specific Ferroptosis
Angewandte Chemie International Edition · 09.01.2026 · 65 (2)
DOI: 10.1002/anie.202509924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 13.11.2025. Verfasst von Ni-Yuan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience …. Hauptthemen laut MEDLINE: Ferroptosis, Antineoplastic Agents, Drug Design, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program, the National Key R&D Program of China.
Abstract (Originalsprache)
Proteolysis‐Targeting Chimera (PROTAC) technology, a groundbreaking approach in drug discovery, leverages the ubiquitin‐proteasome system to degrade disease‐related proteins. Its efficacy mainly hinges on the linker design, which critically influences ternary complex (target protein‐PROTAC‐E3 ligase) stability and pharmacokinetics. However, optimizing linkers for diverse targets remains challenging due to complex structure‐activity relationships and laborious synthesis processes. Herein, we developed a self‐assembled hexamer‐linker Nano‐PROTACs, which was capable of self‐regulating spatial distances, enabling efficient degradation of proteins with different sizes. This barrel‐like hexamer‐linker has a very wide range of universality, enabling the degradation of multiple size proteins (e.g., 22, 55 and 68 kDa), with a degradation efficiency of up to 99%. More importantly, compared to a linear linker, the plasma stability of this self‐assembled hexamer‐linker increased by 48 times. Using Nano‐PROTAC with “double‐gated” system combining epidermal growth factor receptor (EGFR) targeting and ROS‐responsiveness, degradation of the challenging protein glutathione peroxidase 4 (GPX4) was achieved on mouse models, inducing tumor‐specific ferroptosis with reduced off‐target toxicity. This spatially adaptable hexamer‐linker Nano‐PROTAC system offers a universal strategy to streamline PROTAC development, highlighting its transformative potential for targeted protein degradation therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing, 10019…
- State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, P.R. China.
- Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, 450052, P.R. China.
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P.R. China.
- MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, 10084, P.R. China.
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P.R. China.
ORCID-Profile: Hao Wang
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
- the National Key R&D Program of China
- Open Research Fund of State Key Laboratory of Molecular Engineering of Polymers, Fudan University
Zitieren
APA
Zhang, N. Y., Wen, Z., Cai, M. Z., Zhou, K. T., Li, H. Z., Liu, Y. X., Wu, S., Xia, Y., An, H. W., & Wang, H. (2026). De Novo Design of Hexamer‐Linker Dual‐Action Nano‐PROTAC for Tumor‐Specific Ferroptosis. Angewandte Chemie International Edition, 65(2). https://doi.org/10.1002/anie.202509924
Vancouver
Zhang NY, Wen Z, Cai MZ, Zhou KT, Li HZ, Liu YX, et al. De Novo Design of Hexamer‐Linker Dual‐Action Nano‐PROTAC for Tumor‐Specific Ferroptosis. Angewandte Chemie International Edition. 2026;65(2). doi:10.1002/anie.202509924
BibTeX
@article{Zhang2026,
author = {Zhang, Ni-Yuan and Wen, Zhuan and Cai, Ming-Ze and Zhou, Ke-Ting and Li, Hao-Ze and Liu, Yi-Xuan and Wu, Shang and Xia, Yu and An, Hong-Wei and Wang, Hao},
title = {De Novo Design of Hexamer‐Linker Dual‐Action Nano‐PROTAC for Tumor‐Specific Ferroptosis},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {2},
doi = {10.1002/anie.202509924}
}
EUVIMED